CN104244966B - 水母发光蛋白用于减少缺血导致的神经损伤 - Google Patents
水母发光蛋白用于减少缺血导致的神经损伤 Download PDFInfo
- Publication number
- CN104244966B CN104244966B CN201280066993.1A CN201280066993A CN104244966B CN 104244966 B CN104244966 B CN 104244966B CN 201280066993 A CN201280066993 A CN 201280066993A CN 104244966 B CN104244966 B CN 104244966B
- Authority
- CN
- China
- Prior art keywords
- aequorin
- injection
- composition
- cell
- ischemic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161559816P | 2011-11-15 | 2011-11-15 | |
| US61/559,816 | 2011-11-15 | ||
| PCT/US2012/065291 WO2013074798A1 (en) | 2011-11-15 | 2012-11-15 | Apoaequorin for reducing neuronal injury due to ischemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104244966A CN104244966A (zh) | 2014-12-24 |
| CN104244966B true CN104244966B (zh) | 2019-01-11 |
Family
ID=47295186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201280066993.1A Active CN104244966B (zh) | 2011-11-15 | 2012-11-15 | 水母发光蛋白用于减少缺血导致的神经损伤 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20140294874A1 (enExample) |
| EP (1) | EP2780027B1 (enExample) |
| JP (1) | JP6181061B2 (enExample) |
| KR (1) | KR102009932B1 (enExample) |
| CN (1) | CN104244966B (enExample) |
| AU (1) | AU2012340446B2 (enExample) |
| BR (1) | BR112014011630A2 (enExample) |
| CA (1) | CA2855719C (enExample) |
| CY (1) | CY1119300T1 (enExample) |
| DK (1) | DK2780027T3 (enExample) |
| ES (1) | ES2643392T3 (enExample) |
| HR (1) | HRP20171532T1 (enExample) |
| HU (1) | HUE035017T2 (enExample) |
| IL (1) | IL232494B (enExample) |
| IN (1) | IN2014CN04009A (enExample) |
| LT (1) | LT2780027T (enExample) |
| MX (1) | MX350259B (enExample) |
| PL (1) | PL2780027T3 (enExample) |
| PT (1) | PT2780027T (enExample) |
| SG (1) | SG11201402364WA (enExample) |
| SI (1) | SI2780027T1 (enExample) |
| WO (1) | WO2013074798A1 (enExample) |
| ZA (1) | ZA201403577B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA40959A (fr) * | 2014-11-11 | 2017-09-19 | Quincy Bioscience Llc | Compositions contenant de l'apoaéquorine et leurs procédés d'utilisation pour traiter l'inflammation neuronale |
| KR20180001229A (ko) | 2016-06-27 | 2018-01-04 | 삼성에스디아이 주식회사 | 이차 전지의 제조 방법 및 이를 이용한 이차 전지 |
| HUE067969T2 (hu) * | 2016-09-23 | 2024-12-28 | Quincy Bioscience Llc | Apoaequorint és D-vitamint tartalmazó készítmények és alkalmazási eljárásaik |
| RU2642961C1 (ru) * | 2017-02-21 | 2018-01-29 | Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") | Способ профилактики ишемии головного мозга |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101437845A (zh) * | 2006-02-15 | 2009-05-20 | 莫沃斯技术有限公司 | 细胞凋亡的方法、基因和蛋白 |
| US20110130336A1 (en) * | 2009-10-16 | 2011-06-02 | Quincy Bioscience, Llc | Method of treating ischemic injury using apoaequorin |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060229243A1 (en) * | 2004-06-21 | 2006-10-12 | Quincy Resource Group, Inc. | Aequorin-containing compositions and methods of using same |
| MX2010009753A (es) * | 2008-03-11 | 2010-09-30 | Quincy Bioscience Llc | Composiciones que contienen apoaecuorina y metodos de uso de las mismas. |
| JP5919604B2 (ja) * | 2008-08-08 | 2016-05-18 | イミューノメディクス、インコーポレイテッドＩｍｍｕｎｏｍｅｄｉｃｓ， Ｉｎｃ． | 抗膵癌抗体 |
-
2012
- 2012-11-15 KR KR1020147016261A patent/KR102009932B1/ko active Active
- 2012-11-15 PT PT127959559T patent/PT2780027T/pt unknown
- 2012-11-15 SI SI201231064T patent/SI2780027T1/sl unknown
- 2012-11-15 PL PL12795955T patent/PL2780027T3/pl unknown
- 2012-11-15 EP EP12795955.9A patent/EP2780027B1/en active Active
- 2012-11-15 DK DK12795955.9T patent/DK2780027T3/en active
- 2012-11-15 IN IN4009CHN2014 patent/IN2014CN04009A/en unknown
- 2012-11-15 AU AU2012340446A patent/AU2012340446B2/en active Active
- 2012-11-15 HU HUE12795955A patent/HUE035017T2/en unknown
- 2012-11-15 LT LTEP12795955.9T patent/LT2780027T/lt unknown
- 2012-11-15 MX MX2014005798A patent/MX350259B/es active IP Right Grant
- 2012-11-15 SG SG11201402364WA patent/SG11201402364WA/en unknown
- 2012-11-15 ES ES12795955.9T patent/ES2643392T3/es active Active
- 2012-11-15 JP JP2014542463A patent/JP6181061B2/ja active Active
- 2012-11-15 CN CN201280066993.1A patent/CN104244966B/zh active Active
- 2012-11-15 CA CA2855719A patent/CA2855719C/en active Active
- 2012-11-15 US US14/358,274 patent/US20140294874A1/en not_active Abandoned
- 2012-11-15 HR HRP20171532TT patent/HRP20171532T1/hr unknown
- 2012-11-15 WO PCT/US2012/065291 patent/WO2013074798A1/en not_active Ceased
- 2012-11-15 BR BR112014011630A patent/BR112014011630A2/pt not_active Application Discontinuation
-
2014
- 2014-05-07 IL IL232494A patent/IL232494B/en active IP Right Grant
- 2014-05-16 ZA ZA2014/03577A patent/ZA201403577B/en unknown
-
2017
- 2017-08-08 CY CY20171100851T patent/CY1119300T1/el unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101437845A (zh) * | 2006-02-15 | 2009-05-20 | 莫沃斯技术有限公司 | 细胞凋亡的方法、基因和蛋白 |
| US20110130336A1 (en) * | 2009-10-16 | 2011-06-02 | Quincy Bioscience, Llc | Method of treating ischemic injury using apoaequorin |
Also Published As
| Publication number | Publication date |
|---|---|
| IL232494A0 (en) | 2014-06-30 |
| ES2643392T3 (es) | 2017-11-22 |
| IN2014CN04009A (enExample) | 2015-10-23 |
| WO2013074798A1 (en) | 2013-05-23 |
| CY1119300T1 (el) | 2018-02-14 |
| ZA201403577B (en) | 2015-07-29 |
| HK1202417A1 (en) | 2015-10-02 |
| BR112014011630A2 (pt) | 2017-06-27 |
| KR20140097369A (ko) | 2014-08-06 |
| LT2780027T (lt) | 2017-10-25 |
| HRP20171532T1 (hr) | 2017-11-17 |
| EP2780027A1 (en) | 2014-09-24 |
| AU2012340446B2 (en) | 2017-08-31 |
| SI2780027T1 (sl) | 2017-11-30 |
| MX2014005798A (es) | 2014-05-30 |
| PT2780027T (pt) | 2017-10-04 |
| NZ624736A (en) | 2016-05-27 |
| CA2855719C (en) | 2021-10-26 |
| HUE035017T2 (en) | 2018-03-28 |
| DK2780027T3 (en) | 2017-09-25 |
| US20140294874A1 (en) | 2014-10-02 |
| EP2780027B1 (en) | 2017-07-19 |
| PL2780027T3 (pl) | 2017-11-30 |
| IL232494B (en) | 2019-03-31 |
| JP2014533692A (ja) | 2014-12-15 |
| MX350259B (es) | 2017-08-31 |
| CA2855719A1 (en) | 2013-05-23 |
| SG11201402364WA (en) | 2014-09-26 |
| JP6181061B2 (ja) | 2017-08-16 |
| AU2012340446A1 (en) | 2014-05-29 |
| CN104244966A (zh) | 2014-12-24 |
| KR102009932B1 (ko) | 2019-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2007270686B2 (en) | Anti-cancer therapy comprising an H2-blocker, at least one antiinflammatory agent and a cytotoxic agent | |
| CN104244966B (zh) | 水母发光蛋白用于减少缺血导致的神经损伤 | |
| CN105853421B (zh) | FoxO1选择性抑制剂AS1842856的新用途 | |
| US20170173110A1 (en) | Combination therapy for ameliorating adverse side effects caused by chemotherapy | |
| US10548843B2 (en) | Sustained-release silica composite depot non-steroidal anti-inflammatory drug delivery | |
| JP5298028B2 (ja) | 脳虚血障害治療剤 | |
| Rowland | Use of a deslorelin implant to control aggression in a male bearded dragon (Pogona vitticeps) | |
| KR20080088600A (ko) | 상처 치유 방법의 개선을 위한 소 오스테오폰틴 제제 | |
| HK1202417B (en) | Apoaequorin for reducing neuronal injury due to ischemia | |
| JP6912154B1 (ja) | がん化学療法支持剤、食品及び医薬品 | |
| KR100645268B1 (ko) | 동물약품용 약제학적 조성물 | |
| NZ624736B2 (en) | Apoaequorin for reducing neuronal injury due to ischemia | |
| Herdiana et al. | Drug Delivery System in Feline Yedi Herdiana1, 2, Gofarana Wilar2, 3, Ferry Ferdiansyah Sofian4, Annisa Dyah Pitaloka4, Yasinta Nurhijriah4, Rayhan Zarra Safira4, Annisa Siti Salsabila4, Maziyatunisa Z4 | |
| CN117695298A (zh) | 飞燕草素-3-o-葡萄糖苷在制备抗肺纤维化药品或保健品中的应用 | |
| Chen et al. | Perioperative Intestinal Injury: Etiology, Mechanism, and Prevention | |
| CN103520701A (zh) | A型肉毒菌素在制备用于术前预防神经病理性疼痛中的药物中的应用 | |
| TW202510892A (zh) | 用於預防、改善及／或治療肌肉疾病或肌肉失調之組合 | |
| CN119015281A (zh) | 一种苯甲酰胺类化合物防治恶性肿瘤恶病质的用途 | |
| Alipour et al. | Comparison of Analgesic Effects of B Vitamins and Diclofenac plus B Vitamins During General Anesthesia and PACU | |
| CN118059105A (zh) | 一种降血压的药物组合物 | |
| CN117017961A (zh) | 一种莱菔素及其组合物在制备抗疲劳产品中的应用 | |
| KR20140104932A (ko) | 당뇨병성 창상의 예방 또는 치료용 약학 조성물 | |
| CN114945364A (zh) | 用于癌症治疗的组合及其应用 | |
| JPWO2007074727A1 (ja) | 口腔カンジダ症治療剤 | |
| USZ et al. | Buprenorphine via drinking water and combined oral-injection protocols for pain relief in mice |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20250319 Address after: texas Patentee after: Jingshui Bioscience Group Co.,Ltd. Country or region after: U.S.A. Address before: Wisconsin Patentee before: Quincy Bioscience, LLC Country or region before: U.S.A. |
|
| TR01 | Transfer of patent right |